Finding the Sweet Spot for Donor Lymphocyte Infusions

Biology of Blood and Marrow Transplantation

Volumn 19, Issue 4, 2013, Pages 507-508

  Yun, Hyun Don ^a   Waller, Edmund K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; DISEASE MODEL; DONOR LYMPHOCYTE INFUSION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; IN VIVO CULTURE; MULTIPLE MYELOMA; NOTE; OVERALL SURVIVAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TREATMENT OUTCOME;

EID: 84875518025     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.02.005     Document Type: Note

References (12)

1. Krishnamurthy, et al. Outcome of Donor Lymphocyte Infusion after T Celledepleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes. Biol Blood Marrow Transplant 2013, 19:562-568.
2. Liga M., Triantafyllou E., Tiniakou M., et al. High alloreactivity of low-dose prophylactic donor lymphocyte infusion in patients with acute leukemia undergoing allogeneic hematopoietic cell transplantation with an alemtuzumab-containing conditioning regimen. Biol Blood Marrow Transplant 2013, 19:75-81.
3. Waller E.K., Boyer M. New strategies in allogeneic stem cell transplantation: immunotherapy using irradiated allogeneic T cells. Bone Marrow Transplant 2000, 25(suppl 2):S20-S24.
4. Di Ianni M., Falzetti F., Carotti A., et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 2011, 117:3921-3928.
5. Levine J.E., Braun T., Penza S.L., et al. Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation. Journal of Clinical Oncology Jan 15 2002, 20(2):405-412.
6. Ghiso A., Gualandi F., Dominietto A., et al. Donor lymphocyte infusion (DLI) following haplo bone marrow transplantation (hBMT) with high-dose cyclophosphamide post-transplant as GVHD prophylaxis. Blood 2012, 120. abstract 1950.
7. Meyer R.G., Britten C.M., Wehler D., et al. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation. Blood 2007, 109:374-382.
8. Alyea E., Weller E., Schlossman R., et al. T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect. Blood 2001, 8:934-939.
9. Bellucci R., Alyea E.P., Weller E., et al. Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma. Blood 2002, 99:4610-4617.
10. Ferra C., Rodriguez-Luaces M., Gallardo D., et al. Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001, 48:963-968.
11. +-selected cells followed by early T-cell add-backs: favorable results in acute and chronic myeloid leukemia. Cytotherapy 2004, 6:533-542.
12. Lee C.K., de Magalhaes-Silverman M., Hohl R.J., et al. Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma. Bone Marrow Transplant 2002, 29:615-620.